Emergent Biosolutions | search
Click here to view Emergent Biosolutions news from 60+ newspapers.
Bookmark or Share- Emergent BioSolutions Announces Amendment to its Existing Credit ...GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility. “In light of this amendment, Emergent now has an extended runway to execute on our go-forward business plan to stabilize our financial position,” stated Joe Papa, president and CEO of ...
- About Us – Emergent BioSolutionsAt Emergent, we develop, manufacture, and deliver protections against public health threats through a pipeline of innovative vaccines and therapeutics worldwide. For 25 years, we’ve been at work defending people from things we hope will never happen—so that we’re prepared, just in case they ever do.
- Federal Government Cuts Ties With Troubled Vaccine MakerFederal Government Cuts Ties With Troubled Vaccine Maker. Emergent BioSolutions ruined millions of doses of Covid-19 vaccines. Now its $600 million deal is canceled. One of Emergent BioSolutions ...
- Our Products – Emergent BioSolutionsOur Products. We develop, manufacture, and deliver medical countermeasures that address public health threats.
- Investors | Emergent BioSolutions Inc.Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis. As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN ® Nasal Spray and build on its ...
More
